bacterial charity work leads population-wide resistance
bacteria show remarkable adaptability face antibiotic therapeutics resistance alleles drug target-specific sites general stress responses identified individual end-point isolates- less known however population dynamics development antibiotic-resistant strains follow continuous culture escherichia coli facing increasing levels antibiotic show vast majority isolates less resistant population whole find highly resistant mutants improve survival populations less resistant constituents part producing indole signalling molecule generated actively growing unstressed cells show transcriptional profiling indole serves turn drug efflux pumps oxidative-stress protective mechanisms indole production comes fitness cost highly resistant isolates whole-genome sequencing reveals bacterial altruism made possible drug-resistance mutations unrelated indole production work establishes population-based resistance mechanism constituting form kin selection whereby small number resistant mutants can cost provide protection vulnerable cells enhancing survival capacity overall population stressful environments
